TCF7 and neoplasm: Knockout of NR4a1/2 increases the proportion of TCF1+ exhaustion precursor CD8+ T cells, boosts both glycolysis as well as oxidative phosphorylation, and enhances T cell persistence within the tumor microenvironment 60.